Related Experiment Video
Updated: Mar 10, 2026

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
Published on: March 24, 2017
IRF5 governs liver macrophage activation that promotes hepatic fibrosis in mice and humans
Fawaz Alzaid1, Floriane Lagadec2, Miguel Albuquerque2
1Institut National de la Santé et de la Recherche Médicale (INSERM) UMRS 1138, Sorbonne Universités, UPMC Université Paris 06; Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot; and Centre de Recherche des Cordeliers, Paris, France.
Abstract:
Hepatic fibrosis arises from inflammation in the liver initiated by resident macrophage activation and massive leukocyte accumulation. Hepatic macrophages hold a central position in maintaining homeostasis in the liver and in the pathogenesis of acute and chronic liver injury linked to fibrogenesis. Interferon regulatory factor 5 (IRF5) has recently emerged as an important proinflammatory transcription factor involved in macrophage activation under acute and chronic inflammation. Here, we revealed that IRF5 is significantly induced in liver macrophages from human subjects developing liver fibrosis from nonalcoholic fatty liver disease or hepatitis C virus infection. Furthermore, IRF5 expression positively correlated with clinical markers of liver damage, such as plasma transaminase and bilirubin levels. Interestingly, mice lacking IRF5 in myeloid cells (MKO) were protected from hepatic fibrosis induced by metabolic or toxic stresses. Transcriptional reprogramming of macrophages lacking IRF5 was characterized by immunosuppressive and antiapoptotic properties. Consequently, IRF5 MKO mice respond to hepatocellular stress by promoting hepatocyte survival, leading to complete protection from hepatic fibrogenesis. Our findings reveal a regulatory network, governed by IRF5, that mediates hepatocyte death and liver fibrosis in mice and humans. Therefore, modulating IRF5 function may be an attractive approach to experimental therapeutics in fibroinflammatory liver disease.
Insights
Interferon regulatory factor 5 (IRF5) drives liver inflammation and fibrosis by activating macrophages. Inhibiting IRF5 protects against liver damage and fibrogenesis, offering a potential therapeutic target for liver disease.
Area of Science:
- Immunology
- Hepatology
- Molecular Biology
Background:
- Hepatic fibrosis results from liver inflammation, macrophage activation, and leukocyte accumulation.
- Hepatic macrophages are crucial in liver homeostasis and the pathogenesis of liver injury and fibrogenesis.
- Interferon regulatory factor 5 (IRF5) is a key transcription factor in macrophage activation during inflammation.
Purpose of the Study:
- To investigate the role of IRF5 in liver macrophages in the context of hepatic fibrosis.
- To determine if IRF5 modulates hepatocyte survival and fibrogenesis.
Main Methods:
- Analysis of IRF5 expression in liver macrophages from human patients with liver fibrosis (NASH, HCV).
- Correlation of IRF5 levels with clinical markers of liver damage.
- Assessment of hepatic fibrosis in myeloid cell-specific IRF5 knockout (MKO) mice under metabolic or toxic stress.
- Transcriptional analysis of macrophages from IRF5 MKO mice.
Main Results:
- IRF5 was significantly induced in liver macrophages of human subjects with fibrosis.
- IRF5 expression correlated positively with liver damage markers (transaminases, bilirubin).
- IRF5 MKO mice were protected from induced hepatic fibrosis.
- IRF5-deficient macrophages exhibited immunosuppressive and antiapoptotic properties.
- IRF5 MKO mice showed enhanced hepatocyte survival and protection from fibrogenesis.
Conclusions:
- IRF5 plays a critical role in mediating hepatocyte death and liver fibrosis.
- IRF5 orchestrates a pro-inflammatory network in liver macrophages contributing to fibrogenesis.
- Targeting IRF5 presents a promising therapeutic strategy for fibroinflammatory liver diseases.
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Regulation of the Unfolded Protein Response

